{"id":208,"date":"2019-03-13T16:15:57","date_gmt":"2019-03-13T23:15:57","guid":{"rendered":"https:\/\/blogs.ubc.ca\/daugaardlab\/?page_id=208"},"modified":"2021-09-14T15:33:10","modified_gmt":"2021-09-14T22:33:10","slug":"publications","status":"publish","type":"page","link":"https:\/\/blogs.ubc.ca\/daugaardlab\/publications\/","title":{"rendered":"Selected Publications"},"content":{"rendered":"

1.\tOo, H.Z., et al., Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer. Cancers (Basel), 2021. 13(17): p. 4489.<\/a><\/p>\n

2.\tVoskuilen, C.S., et al., Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Carcinoma. Am J Surg Pathol, 2019.<\/a><\/p>\n

3.\tOo, H.Z., et al., Post-translational modifications in bladder cancer: Expanding the tumor target repertoire. Urol Oncol, 2018.<\/a><\/p>\n

4.\tZhai, B., et al., Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination. Cell Death Dis, 2018. 9(10): p. 1016.<\/a><\/p>\n

5.\tAgerb\u00e6k, M., et al., The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner. Nat Commun, 2018. 9(1): p. 3279.<\/a><\/p>\n

6.\tSeiler, R., et al., An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer. Eur Urol, 2017. 72(1): p. 142-150.<\/a><\/p>\n

7.\tAyres Pereira, M., et al., Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1. PLoS Pathog, 2016. 12(8): p. e1005831.<\/a><\/p>\n

8.\tClausen, T.M., et al., Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility. Mol Cancer Res, 2016. 14(12): p. 1288-1299.<\/a><\/p>\n

9.\tClausen, T.M., et al., Real-time and label free determination of ligand binding-kinetics to primary cancer tissue specimens; a novel tool for the assessment of biomarker targeting. Sens Biosensing Res, 2016. 9: p. 23-30.<\/a><\/p>\n

10.\tSalanti, A., et al., Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein. Cancer Cell, 2015. 28(4): p. 500-514.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

1. Oo, H.Z., et al., Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer. Cancers (Basel), 2021. 13(17): p. 4489. 2. Voskuilen, C.S., et al., Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Carcinoma. Am J Surg Pathol, 2019. 3. Oo, H.Z., et al., Post-translational … <\/p>\n

Continue reading “Selected Publications”<\/span><\/a><\/p>\n","protected":false},"author":64086,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-208","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/blogs.ubc.ca\/daugaardlab\/wp-json\/wp\/v2\/pages\/208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.ubc.ca\/daugaardlab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/blogs.ubc.ca\/daugaardlab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.ubc.ca\/daugaardlab\/wp-json\/wp\/v2\/users\/64086"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.ubc.ca\/daugaardlab\/wp-json\/wp\/v2\/comments?post=208"}],"version-history":[{"count":8,"href":"https:\/\/blogs.ubc.ca\/daugaardlab\/wp-json\/wp\/v2\/pages\/208\/revisions"}],"predecessor-version":[{"id":519,"href":"https:\/\/blogs.ubc.ca\/daugaardlab\/wp-json\/wp\/v2\/pages\/208\/revisions\/519"}],"wp:attachment":[{"href":"https:\/\/blogs.ubc.ca\/daugaardlab\/wp-json\/wp\/v2\/media?parent=208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}